Hexima - HXL(ASX) News & Expert Insights from Stockhead

Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Hexima.

Check up: 78 biotech companies rocked the boat this week but only one has real news

January 5, 2022May 19, 2022 | Jessica Cummins

Health & Biotech

China is about to grant patents like never before, and these ASX stocks have already got some

November 9, 2021November 8, 2021 | Eddy Sunarto

Health & Biotech

ASX Health Stocks: AFT Pharma jumps 13pc on FDA submission, Imugene up 10pc on CAR-T progress

November 1, 2021November 1, 2021 | Eddy Sunarto

News

September Winners Column: A rough month but uranium and lithium managed gains. And caravan renters

October 4, 2021October 3, 2021 | Nick Sundich

paradigm biopharmaceuticals asx par trial

Health & Biotech

Check Up: Paradigm targets Phase 3 clinical trial in the US; AI microbiology product fails to impress

September 29, 2021September 29, 2021 | Emma Davies

Health & Biotech

Check Up: ASX biotech comes alive as health stocks tackle international markets

September 15, 2021September 15, 2021 | Eddy Sunarto

News

Rise and Shine: What you need to know before the ASX opens

August 20, 2021August 20, 2021 | Reuben Adams

Health & Biotech

Check Up: Hexima roars 70pc on clinical trials, while Bionomics heads for a US dual listing

August 5, 2021August 4, 2021 | Eddy Sunarto

Hexima
(ASX:HXL)

HXL Share Price and Trading History

RELATED STOCKHEAD STORIES

Check up: 78 biotech companies rocked the boat this week but only one has real news

China is about to grant patents like never before, and these ASX stocks have already got some

ASX Health Stocks: AFT Pharma jumps 13pc on FDA submission, Imugene up 10pc on CAR-T progress

September Winners Column: A rough month but uranium and lithium managed gains. And caravan renters

Check Up: Paradigm targets Phase 3 clinical trial in the US; AI microbiology product fails to impress

Check Up: ASX biotech comes alive as health stocks tackle international markets

Rise and Shine: What you need to know before the ASX opens

Check Up: Hexima roars 70pc on clinical trials, while Bionomics heads for a US dual listing

HXL Share Price and Trading History

Hear it first

Thanks! You’re subscribed, Stockhead news is coming your way soon.

HXL Share Price and Trading History

RELATED STOCKHEAD STORIES

HXL Share Price and Trading History

Don't be the last to know

Editor's Picks

Lessons from the Masters: Where is super prospector Mark Creasy looking for his next payday after Galileo's big hit?

FREE WHELAN: ARK attracts more PAIN thusly I almost spat my coffee out

With food at record prices, here's how ASX investors could play the growing global crisis

Uranium inventories are scarily low – here’s what that means for energy security, prices and new projects

Scott's Super Home Buyer fix is not a solution... because the boom ain't over, it's just left the city

Get the latest Stockhead news delivered free to your inbox

I want the news:

Hear it first

Thanks! You’re subscribed, Stockhead news is coming your way soon.